Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)
Clinical trial NCT03131219 · COMPLETED
Trial details
- NCT number
- NCT03131219
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-31
- Primary completion
- 2022-12-20
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.